Purpose: To compare the IOP diurnal fluctuations of glaucoma patients treated with latanoprost 0.005% once a day to patients with controlled IOP after deep sclerectomy or trabeculectomy.
Methods: The trial included 60 prospectively recruited subjects with POAG. The medical group consisted of 20 patients with controlled IOP (<18 mmHg) under latanoprost 0.005% monotherapy and with no history of previous intraocular surgery or argon laser trabeculoplasty; the surgical groups included 20 patients after trabeculectomy (TE), and 20 patients after deep sclerectomy with collagen implant (DSCI). The patients in the surgical groups had a controlled IOP without any ocular hypotensive medications. All patients underwent a diurnal tension curve (8.00 – 17.00/3-hour intervals), followed by a water-drinking test (WDT) with the last IOP measurement taken at 21.00. The between-group differences were tested for significance by means of analysis of variance (ANOVA).
Results: Baseline IOP was significantly different between the TE group (10.1 ± 3.4 mmHg), the DSCI group (13.9 ± 2.8 mmHg) and the latanoprost group (15.5 ± 2.0 mmHg) (p = 0.005). The average IOP during the diurnal tension curve (10.1 mmHg, 13.7 mmHg , and 15.7 mmHg respectively for the groups TE, DSCI, and latanoprost) differed significantly between the groups (ANOVA: p <0.0001), but the variation was comparable in the three groups (ANOVA: p = 0.13). Following the WDT, elevation of IOP was significantly larger among patients treated with latanoprost (p = 0.003).
Conclusion: Trabeculectomy patients had a statistically significant lower average IOP in the diurnal tension curve compared to the other two groups. No wider variation in diurnal IOP with latanoprost compared to the surgical procedures was found. However, IOP increase during WDT was most marked in patients under latanoprost therapy.
- glaucoma surgery
- intraocular pressure